FDA Output, November 2024
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in November 2024. Updated November 19.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in November 2024. Updated November 19.
Led by Boston Scientific veterans and its technology’s co-inventor, Amplitude Vascular Systems is sponsoring the pivotal trial for a novel intravascular lithotripsy system that it believes will make up ground on Shockwave, the Johnson & Johnson subsidiary that established this billion-dollar market.
The EU lays out expectations for a pending mandate to disclose anticipated shortages. Excerpted from Pathways’ Picks October 30 4: EU Shortage Reporting Guide, Upcoming Medicare Rules, and More